kupdf.net_manual-practico-medicina-estetica
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Hipercromías y melasma
mantenerse los resultados recurriendo al
empleo de productos blanqueadores y a
una adecuada fotoprotección.
Lucía López Agüero
lucyk@infovia.com.ar
R eferencias bibliográficas
1. Fitzpatrick TB, Ortonne JP. Trastorno de
los melanocitos en Fitzpatrick Dermatología en
Medicina General de fP Freedberg, Eisen, Wolff,
Austen, Goldsmith, Katz. Cap. 88, pp 920-2005,
Editorial Panamericana ISBN: 950-06-0733-6
2. Cordero AA. Biología de Piel, estructura y fimckmes.
Ed Médica Panamericana1996 Pp 110. ISBN: 95006-0415-9
3. Bolognia JL, Jorizzo JL, Rapini R. Melanocyte
biology en Dermatology de JL Bolognia, Seth J
Orlow. 2008, Cap 64 pp 901-912 Elsevier Limited.
ISBN: 9781416029991
4. http://www.camaracecep.com.arlnotaclase.html
5. Luger TA, Scholzen T, Grabbe S. The rol o f
alpha-melanocyte-stimulating hormone in cutaneus
biology. J Invest Dermatol Symp Proc.l997;2:87-93
6. Spencer JD, Chavan B, Marles LK, Kauser S,
Rokos H, Schallreuter KU. A novel mechanism in
control o f human pigmentation by {betaj-melanocytestimulating
hormone and 7-tetrahydrobiopterin. J
■Endocrinol. 2005 Nov;187(2):293-302
7. Sánchez-Mds J, Hahmann C, Gerritsen I,
García-Borrón JC, Jiménez-Cervantes, C. Agonistindependent,
high constitutive activity ofthe human
melanocortin 1 receptor. Pigment Cell Res. 2004
Aug;17(4):386-395.
8. García-Borrón JC, Sánchez-Laorden BL, Jiménez-
Cervantes, C. Melanocortin-1 receptor structure and
jündional legulation. Pigment Cell Res. 2005Dec; 18(6)393-410
9.http://books.google.com.ar/books?id=imPn2IRlc94
C&pg-PA37&lpg=PA37&’dq=proteina+P+y+mela
nogenesis&source=web&ots=BCu-xTFJMO&sig=_
dkFgcKvTv7BvjjPNjsqkwkgvM&hl=es&sa=X&oi=book_
result&resnum=l &ct=result
10. Jimbow K, Gómez PF, Toyofuku K, Chang D,
Miura S, Tsujiya H, Park JS. Biological role o f
tyrosinase related protein and its biosíntesis ans
transportfrom TGN tostagel melanosome, late endosóme,
through gene transfection study. Pigment Cell Res.
1997 Aug; 10(4):206-213
11. Mishima M. Molecular and biological control
o f melanogenesis through tyrosinase genes and
intrinsic and extrinsic regulatory factors. Pigment
Cell Res. 1994 Dec; 7(6):376-387.
12. Schwahn DJ, Xu W, Herrín AB, Bales
ES, Medrano EE. Tyrosine levels regúlate the
melanogenic response to alpha-melanocytestimulating
hormone in human melanocytes:
implications for pigmentation and proliferation.
Pigment Cell Res. 2001 Feb;14(l):32-39.
13. Bleehen SS, Ebling FJG, Champion RH,
Disorders ofskin colours. In Champion RH, Burton
JL, Ebling FJG, eds, Text book o f Dermatology 5th
edn. Blackwell: Oxford 1992. pp 1593-1618
14. Lee J, Jung E, Lee J, Hidi S, Boo YC, Hyun CG,
Kim YS, Park D. Mechanisms o f melanogenesis
inhibition by 2,5-dimethyl-4-hydroxy-3(2H)-furanone.
Br J Dermatol. 2007 Aug;157(2):242-248
15. Gilchrest BA, Fitzpatrick TB, Anderson RR,
Parrish JA. Localization ofm elanin pigmentation in
the skin with Wood s lanrp. Brj DermatoL 1977,96:245-248.
16. Hassan I, Kaur 1, Sialy R, Dash RJ, Hormonal
milieu in the maintenance o f melasma in fértil
women. J Dermatol. 1998 Aug;25(8):510-512.
17. Sialy R, Hassan I, Kaur I, Dash RJ. Melasma in
men: a hormonal profile. J Dermatol. 2000 Jan;27 (l):64-65
18. Kurita M, Kato H, Yoshimura K. A therapeutic
strategy based on histological assessment o f
hyperpigmented skin lesions in Asians. J Plast
Reconstr Aesthet Surg. 2008 May 2. Epub ahead of
print MID: 18456589 PubMed-as supplied bypublisher
19. Kim EH, Kim YC, Lee ES, Kang HY. The
vascular characteristics o f melasma. J Dermatol Sci.
2007 M ay;46(2):lll-116.
20. Bolognia JL, Jorizzo JL, Rapini R. Melanocyte
biology. Disorders o f hyperpigmentation, en
Dermatology vol 1. de Mary Wu Chang. Second ed,
Cap. 66 pp 939-954 2008 Elsevier Limited ISBN:
9781416029991
21. Bhor U, Pande S. Scoring systems in dermatology.
Indian J Dermatol Venereol Leprol 2006 72:315-21.
22.Kimbrough-GreenCK,GriffithsCE,FinkelLJ,Hamilton
TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ. Topical
retinoic acid (tretinoin) for melasma in black patients. A
vehide-coi ibdled cliniai trici Airh Dermatol 1994;130:727-733.
23. Piqueiv-Martíh J, Piquero-Casals J. Diagnóstico y
tratamiento del melasma. Piel 2000; 15:182-187.
24. Ilya Petrou. Treating melasma: Copper bromide láser
effectively targets vasculature. Dermatology Times. Nov
1, 2008.
115